Klinische Studie

Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)

NCT: NCT04502316 · TERMINATED

NCT-IDNCT04502316

Medizinische Daten: StatusTERMINATED

Startdatum2020-06-26

Abschluss2026-06-30

SponsorCVRx, Inc. (INDUSTRY)

First posted2020-08-06

Last updated2026-09-17

Kurzzusammenfassung

The purpose of this registry is to develop valid scientific evidence of the safety and benefit of Barostim Therapy in the commercial setting in patients with heart failure with reduced ejection fraction (HFrEF) that were recently implanted with the Barostim System.

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.